Thromboxane A2 does not contribute to arrhythmogenesis during evolving canine myocardial infarction.
Kramer, J B
Thromboxane A2 does not contribute to arrhythmogenesis during evolving canine myocardial infarction. [electronic resource] - Journal of cardiovascular pharmacology - 1069-76 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0160-2446
10.1097/00005344-198511000-00009 doi
Action Potentials--drug effects
Animals
Arrhythmias, Cardiac--etiology
Blood Pressure--drug effects
Dogs
Electric Stimulation
Heart Conduction System--drug effects
Heart Rate--drug effects
In Vitro Techniques
Myocardial Infarction--complications
Thromboxane A2--pharmacology
Thromboxane A2 does not contribute to arrhythmogenesis during evolving canine myocardial infarction. [electronic resource] - Journal of cardiovascular pharmacology - 1069-76 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0160-2446
10.1097/00005344-198511000-00009 doi
Action Potentials--drug effects
Animals
Arrhythmias, Cardiac--etiology
Blood Pressure--drug effects
Dogs
Electric Stimulation
Heart Conduction System--drug effects
Heart Rate--drug effects
In Vitro Techniques
Myocardial Infarction--complications
Thromboxane A2--pharmacology